Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blinded, Placebo Controlled Phase III Clinical Trial of SARS-CoV-2 Vaccine, Inactivated (Vero Cell) in Adults Aged 18 Years and Above
Conditions
Interventions
Inactivated SARS-CoV-2 Vaccine (Vero cell)
Placebo
Locations
2
Brazil
CEMEC Pesquisa Clinica
São Bernardo do Campo, São Paulo, Brazil
Hospital Sungai Buloh
Sungai Buloh, Selangor, Malaysia
Start Date
January 28, 2021
Primary Completion Date
September 1, 2021
Completion Date
July 1, 2022
Last Updated
February 10, 2021
NCT06082518
NCT07221162
NCT06631287
NCT06679140
NCT06417762
NCT03830320
Lead Sponsor
Chinese Academy of Medical Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions